HOWLWerewolf Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Werewolf Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOWLEsta | $49M#8 | — | 3.0x#5 | — | — | 13.7%#3 | — | -373.3%#6 | -229.9%#2 | — | -22.2%#2 | — |
| YARW | $52M#1 | 2.3x#1 | 2.4x#4 | 91.3x#2 | 13.8%#3 | 33.5%#2 | -5219.1%#1 | -120.0%#4 | — | — | — | — |
| CALC | $52M#2 | — | 9.4x#7 | — | — | -115.8%#10 | — | -536.2%#7 | — | — | -89.8%#5 | — |
| ANVS | $52M#3 | — | — | — | — | -17.3%#7 | — | — | — | — | -42.1%#3 | — |
| GANX | $51M#4 | — | 4.5x#6 | 925.4x#7 | -58.4%#5 | 1.2%#6 | -33908.5%#5 | -178.5%#5 | — | — | — | — |
| IBIO | $51M#5 | — | 0.6x#2 | 509.6x#5 | -75.0%#6 | -78.7%#9 | -35141.0%#6 | -38.3%#1 | — | — | — | — |
| CLNN | $50M#6 | — | — | 250.2x#3 | -41.5%#4 | 33.6%#1 | -11541.5%#3 | — | — | — | -68.8%#4 | — |
| SER | $50M#7 | — | — | 384.9x#4 | 132.1%#2 | -72.2%#8 | -18478.5%#4 | — | — | 5#1 | — | — |
| HYPD | $49M#9 | — | 0.5x#1 | 60.4x#1 | 1318.8%#1 | 9.0%#5 | -5743.5%#2 | -44.5%#2 | -46.8%#1 | — | — | — |
| ATNM | $47M#10 | 4.3x#2 | 1.5x#3 | 520.5x#6 | — | 11.4%#4 | -40274.4%#7 | -111.8%#3 | — | — | 4.9%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice